Advances in Nanopolymer and Hybrid Materials for Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (30 October 2023) | Viewed by 289
Special Issue Editor
Interests: drug delivery systems; micro and nanoparticles; nanoparticles; hybrid nanocomposites; magnetic nanoparticles for MRI and magnetic hyperthermia; liposomes; polymeric materials; biopolymers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hybrid and nanopolymer systems have become increasingly important in drug delivery due to their surface and volume properties. They are present in both drug delivery formulations and theranostic systems. Nanopolymer systems stand out as an essential tool to improve the bioavailability of biologically active substances or delivery to the target site. Nanopolymer systems are available in a wide variety and are well-chemically characterized. Non-toxic, biodegradable, and biocompatible nanopolymer systems are well known. Some of them can cross the blood–brain barrier, protect active substances against degradation or respond to external stimuli, such as changes in temperature, pH, or ionic strength. The versatility of these systems makes them potentially ideal vehicles for controlled drug delivery. However, it is often necessary to functionalize the nanopolymer system, which allows the properties of the carrier to be adapted to the structure and activity of the delivered drug.
This Special Issue is dedicated to advances in the field of nanopolymers and hybrid drug delivery systems. Studies on all types of nanopolymers and hybrid materials (nanoparticles and nanocapsules, vesicles, polymer–drug conjugates, and other nanostructured materials) are welcome in the form of full papers, communications, and reviews.
Dr. Dorota Lachowicz
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanopolymer materials
- hybrid nanoparticles
- controlled release
- drug delivery system
- targeted delivery
- bioavailability
- theranostic
